Population pharmacokinetics of mycophenolate in patients treated for interstitial lung disease (EVER‐ILD study)

Documenti analoghi

• Population pharmacokinetics of sivelestat in Chinese patients with severe pneumonia
  di: Xiaolin Zhang, et al.
  Pubblicazione: (2025)
• Impacts of genetic polymorphisms and cancer cachexia on naldemedine pharmacokinetics and bowel movements in patients receiving opioid analgesics
  di: Emi Nakatsugawa, et al.
  Pubblicazione: (2024)
• Role of biomarkers and molecular signaling pathways in acute lung injury
  di: Pakter Niri, et al.
  Pubblicazione: (2024)
• Challenges and opportunities of medicines for treating tendon inflammation and fibrosis: A comprehensive and mechanistic review
  di: Zohreh Najafi, et al.
  Pubblicazione: (2024)
• Capivasertib augments chemotherapy via Akt inhibition in preclinical small cell lung cancer models
  di: Cheng Long, et al.
  Pubblicazione: (2024)